Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease

Karen M. Peterson, Federico Franchi, Darrel L. Loeffler, Peter J. Psaltis, Peter C Harris, Lilach O Lerman, Amir Lerman, Martin G Rodriguez-Porcel

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: Polycystic kidney disease (PKD), a monogenic disease with an autosomal dominant or an autosomal recessive form of inheritance (ARPKD), is the most common genetic cause of renal dysfunction and end-stage renal failure. In addition to the development of cysts, the autosomal form of PKD is associated with vascular endothelial dysfunction, a marker of vascular disease. Whether vascular endothelial dysfunction is also present in ARPKD, and its relationship with renal dysfunction remain to be determined. Methods: ARPKD rats (PCK model) and controls were studied at 6 and 10 weeks of age, and mean arterial pressure and renal function were measured. Aortic endothelial function was assessed using organ chamber techniques. Aortic endothelial cells (ECs) were isolated, characterized and their function studied. Results: Compared to controls, ARPKD animals had a decrease in the vasorelaxation to endothelium-dependent vasodilators, even prior to changes in mean arterial pressure or renal function. The abnormal vasoreactivity was corrected with L-arginine (a precursor of nitric oxide, NO), while the expression of endothelial NO synthase (eNOS) was unchanged. Furthermore, isolated ECs from 6-week-old ARPKD animals showed increased oxidative stress, with preserved eNOS expression and abnormal patterns of migration and angiogenic capacity (measured by the scratch and tube formation assays, respectively). Conclusion: ARPKD leads to impairments in aortic vascular function and ECs at an early stage, which can have significant functional consequences, potentially representing a novel therapeutic target in this disease.

Original languageEnglish (US)
Pages (from-to)233-240
Number of pages8
JournalAmerican Journal of Nephrology
Volume38
Issue number3
DOIs
StatePublished - Sep 2013

Fingerprint

Autosomal Recessive Polycystic Kidney
Polycystic Kidney Diseases
Kidney
Endothelial Cells
Blood Vessels
Arterial Pressure
Endothelium-Dependent Relaxing Factors
Nitric Oxide Synthase Type III
Vascular Diseases
Vasodilation
Nitric Oxide Synthase
Chronic Kidney Failure
Arginine
Cysts
Nitric Oxide
Oxidative Stress

Keywords

  • Acetylcholine
  • Autosomal inheritance
  • Cardiovascular disease
  • Endothelial dysfunction
  • Polycystic kidney disease

ASJC Scopus subject areas

  • Nephrology

Cite this

Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease. / Peterson, Karen M.; Franchi, Federico; Loeffler, Darrel L.; Psaltis, Peter J.; Harris, Peter C; Lerman, Lilach O; Lerman, Amir; Rodriguez-Porcel, Martin G.

In: American Journal of Nephrology, Vol. 38, No. 3, 09.2013, p. 233-240.

Research output: Contribution to journalArticle

@article{872516fd339345a39a798cf44c260e0b,
title = "Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease",
abstract = "Objective: Polycystic kidney disease (PKD), a monogenic disease with an autosomal dominant or an autosomal recessive form of inheritance (ARPKD), is the most common genetic cause of renal dysfunction and end-stage renal failure. In addition to the development of cysts, the autosomal form of PKD is associated with vascular endothelial dysfunction, a marker of vascular disease. Whether vascular endothelial dysfunction is also present in ARPKD, and its relationship with renal dysfunction remain to be determined. Methods: ARPKD rats (PCK model) and controls were studied at 6 and 10 weeks of age, and mean arterial pressure and renal function were measured. Aortic endothelial function was assessed using organ chamber techniques. Aortic endothelial cells (ECs) were isolated, characterized and their function studied. Results: Compared to controls, ARPKD animals had a decrease in the vasorelaxation to endothelium-dependent vasodilators, even prior to changes in mean arterial pressure or renal function. The abnormal vasoreactivity was corrected with L-arginine (a precursor of nitric oxide, NO), while the expression of endothelial NO synthase (eNOS) was unchanged. Furthermore, isolated ECs from 6-week-old ARPKD animals showed increased oxidative stress, with preserved eNOS expression and abnormal patterns of migration and angiogenic capacity (measured by the scratch and tube formation assays, respectively). Conclusion: ARPKD leads to impairments in aortic vascular function and ECs at an early stage, which can have significant functional consequences, potentially representing a novel therapeutic target in this disease.",
keywords = "Acetylcholine, Autosomal inheritance, Cardiovascular disease, Endothelial dysfunction, Polycystic kidney disease",
author = "Peterson, {Karen M.} and Federico Franchi and Loeffler, {Darrel L.} and Psaltis, {Peter J.} and Harris, {Peter C} and Lerman, {Lilach O} and Amir Lerman and Rodriguez-Porcel, {Martin G}",
year = "2013",
month = "9",
doi = "10.1159/000354236",
language = "English (US)",
volume = "38",
pages = "233--240",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease

AU - Peterson, Karen M.

AU - Franchi, Federico

AU - Loeffler, Darrel L.

AU - Psaltis, Peter J.

AU - Harris, Peter C

AU - Lerman, Lilach O

AU - Lerman, Amir

AU - Rodriguez-Porcel, Martin G

PY - 2013/9

Y1 - 2013/9

N2 - Objective: Polycystic kidney disease (PKD), a monogenic disease with an autosomal dominant or an autosomal recessive form of inheritance (ARPKD), is the most common genetic cause of renal dysfunction and end-stage renal failure. In addition to the development of cysts, the autosomal form of PKD is associated with vascular endothelial dysfunction, a marker of vascular disease. Whether vascular endothelial dysfunction is also present in ARPKD, and its relationship with renal dysfunction remain to be determined. Methods: ARPKD rats (PCK model) and controls were studied at 6 and 10 weeks of age, and mean arterial pressure and renal function were measured. Aortic endothelial function was assessed using organ chamber techniques. Aortic endothelial cells (ECs) were isolated, characterized and their function studied. Results: Compared to controls, ARPKD animals had a decrease in the vasorelaxation to endothelium-dependent vasodilators, even prior to changes in mean arterial pressure or renal function. The abnormal vasoreactivity was corrected with L-arginine (a precursor of nitric oxide, NO), while the expression of endothelial NO synthase (eNOS) was unchanged. Furthermore, isolated ECs from 6-week-old ARPKD animals showed increased oxidative stress, with preserved eNOS expression and abnormal patterns of migration and angiogenic capacity (measured by the scratch and tube formation assays, respectively). Conclusion: ARPKD leads to impairments in aortic vascular function and ECs at an early stage, which can have significant functional consequences, potentially representing a novel therapeutic target in this disease.

AB - Objective: Polycystic kidney disease (PKD), a monogenic disease with an autosomal dominant or an autosomal recessive form of inheritance (ARPKD), is the most common genetic cause of renal dysfunction and end-stage renal failure. In addition to the development of cysts, the autosomal form of PKD is associated with vascular endothelial dysfunction, a marker of vascular disease. Whether vascular endothelial dysfunction is also present in ARPKD, and its relationship with renal dysfunction remain to be determined. Methods: ARPKD rats (PCK model) and controls were studied at 6 and 10 weeks of age, and mean arterial pressure and renal function were measured. Aortic endothelial function was assessed using organ chamber techniques. Aortic endothelial cells (ECs) were isolated, characterized and their function studied. Results: Compared to controls, ARPKD animals had a decrease in the vasorelaxation to endothelium-dependent vasodilators, even prior to changes in mean arterial pressure or renal function. The abnormal vasoreactivity was corrected with L-arginine (a precursor of nitric oxide, NO), while the expression of endothelial NO synthase (eNOS) was unchanged. Furthermore, isolated ECs from 6-week-old ARPKD animals showed increased oxidative stress, with preserved eNOS expression and abnormal patterns of migration and angiogenic capacity (measured by the scratch and tube formation assays, respectively). Conclusion: ARPKD leads to impairments in aortic vascular function and ECs at an early stage, which can have significant functional consequences, potentially representing a novel therapeutic target in this disease.

KW - Acetylcholine

KW - Autosomal inheritance

KW - Cardiovascular disease

KW - Endothelial dysfunction

KW - Polycystic kidney disease

UR - http://www.scopus.com/inward/record.url?scp=84885032006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885032006&partnerID=8YFLogxK

U2 - 10.1159/000354236

DO - 10.1159/000354236

M3 - Article

C2 - 24008943

AN - SCOPUS:84885032006

VL - 38

SP - 233

EP - 240

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

IS - 3

ER -